Stratagene Refutes Third Wave s Patent-Infringement Lawsuit Over PCR Reagents | GenomeWeb

NEW YORK, Sept. 17 (GenomeWeb News) - Stratagene said yesterday that a patent infringement lawsuit Third Wave filed against it on Wednesday is without  merit.

"We are surprised that Third Wave would file this lawsuit before discussing with us the differences in the two companies' technologies," Joseph Sorge, Stratagene's chairman and CEO, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.